NCT04478357
- Conditions
- Neurogenic Detrusor Overactivity
- Locations
-
- Brussels Clinical Research Unit Brussels, Bruxelles-capitale, Région de, Belgium
Clinical trial condition
Neurogenic Detrusor Overactivity
Explore clinical trials studying Neurogenic Detrusor Overactivity. Study availability and eligibility vary by location and protocol.
19 public trials
3 recruiting studies
Neurogenic Detrusor Overactivity trial results
- Conditions
- Neurogenic Detrusor Overactivity
- Locations
-
- Brussels Clinical Research Unit Brussels, Bruxelles-capitale, Région de, Belgium
Completed
Effects of Rec 0/0438 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury
NCT03482037
- Conditions
- Neurogenic Detrusor Overactivity
- Locations
-
- Recordati Investigative Site Prague, Czechia
- Department of Urology, Academic hospital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Pierre et Marie Curie Medical School, Sorbonne Universités Paris, France
- Centre Hospitalier Lyon Sud Unité de Pharmacie Clinique Oncologique (essai clinique) Pavillon Marcel Bérard - Bât. 1G Pierre-Bénite, France
- Recordati Investigative Site Rouen, France
NCT03168828
- Conditions
- Neurogenic Detrusor Overactivity
- Locations
-
- Michigan Institute of Urology Troy, Michigan, United States
- Carolinas HealthCare System Charlotte, North Carolina, United States
- Urology of Virginia Virginia Beach, Virginia, United States
- Virginia Mason Seattle, Washington, United States
NCT02138149
- Conditions
- Central Nervous System Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +16 more
- Locations
-
- Swiss Paraplegic Centre Nottwil, Canton of Lucerne, Switzerland
NCT00800462
- Conditions
- Central Nervous System Diseases, Nervous System Diseases, Neurogenic Detrusor Overactivity, +5 more
- Locations
-
- University of Manitoba, Health Sciences Centre Winnipeg, Manitoba, Canada
- Toronto Rehabilitation Institute, Lyndhurst Centre Toronto, Ontario, Canada
NCT00857896
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
- Locations
-
- Pfizer Investigational Site Little Rock, Arkansas, United States
- Pfizer Investigational Site Long Beach, California, United States
- Pfizer Investigational Site Overland Park, Kansas, United States
- Pfizer Investigational Site Overland Park, Kansas, United States
Completed
Intravesical Injection of Botulinum Toxin A Versus Saline for Neurogenic Detrusor Overactivity
NCT01091727
- Conditions
- Cone-Rod Dystrophies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +7 more
- Locations
-
- Sunnybrook Health Sciences Centre Toronto, Ontario, Canada
Active, Not Recruiting
A Study to Learn How Effective and Safe the Drug 'Mirabegron' is and How Long it Stays in the Body of Children Aged 6 Months to Less Than 3 Years of Age With Neurogenic Detrusor Overactivity
NCT05621616
- Conditions
- Neurogenic Detrusor Overactivity
- Locations
-
- Site PH63001 Quezon, Philippines
- Site PH63002 Quezon City, Philippines
- Site PL48001 Gdansk, Poland